We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $3.9 · 5 analysts
Stored first · Google News · Yahoo Finance (English)
Lucid Diagnostics (LUCD) Nears One-Dollar Threshold After Modest Decline - Arms Index - dars.gov.et
Lucid Diagnostics (LUCD) Nears One-Dollar Threshold After Modest Decline - Arms Index dars.gov.et
LUCD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
LUCD Financials: Revenue Breakdown, Margins & Competitor Comparison Intellectia AI
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% Drop - Keltner Channel - dars.gov.et
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% Drop - Keltner Channel dars.gov.et
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% Drop - Stock News - dars.gov.et
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% Drop - Stock News dars.gov.et
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) - Seeking Alpha
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) Seeking Alpha
Lucid Diagnostics (LUCD) Edges Higher as Diagnostics Sector Sees Renewed Interest - Dividend Arbitrage - dars.gov.et
Lucid Diagnostics (LUCD) Edges Higher as Diagnostics Sector Sees Renewed Interest - Dividend Arbitrage dars.gov.et
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 12. | After market close (AMC) | $-0.06 | — | — | $1.43M | — | Scheduled |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.87 | — | — | $3.15M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.62 | — | — | $1.98M | Reported |
| FY2025 Q1 | 2024. 03. 31. | Time TBD | — | $-0.4 | — | — | $1M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 16. | Maxim Group | — | Maintain | Buy → Buy | — | Maxim Group: Buy |
| 2026. 05. 15. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 04. 09. | Ascendiant Capital | — | Maintain | Buy → Buy | — | Ascendiant Capital: Buy |
| 2026. 03. 30. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 03. 27. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2025. 12. 10. | Ascendiant Capital | — | Maintain | Buy → Buy | — | Ascendiant Capital: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.